IL2 and neoplasm: Furthermore, our new platform enables us to investigate the effects of co-cultured autologous PBMCs (either unstimulated or after stimulation with IL-2), NK cells, myeloid cells, and macrophages, and to determine whether these autologous cells play a significant tumor patient-individual role in combating PC.